| Use of intravenous tissue plasminogen activator in a 16-year-old patient with basilar occlusion. | |
MedLine Citation:
|
PMID: 18827269 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Intravenous tissue plasminogen activator (t-PA) is currently approved by the US Food and Drug Administration (FDA) for the treatment of ischemic stroke in patients > 18 years of age who present within 3 hours of stroke onset and meet certain criteria. We report a case of a 16-year-old, previously healthy female who presented with a basilar artery occlusion and pontine ischemic stroke. She was treated with intravenous t-PA approximately 4 hours after the onset of symptoms. The patient demonstrated a remarkable recovery 6 hours after onset of her symptoms and had minimal deficits on discharge from the hospital 1 week later. She was found to have a lupus anticoagulant and was heterozygous for the prothrombin gene G2010A mutation. These were likely contributing causes for her stroke. She was also homozygous for plasminogen activator inhibitor 1 (PAI-1) 4G/4G, which at present is a controversial stroke risk factor. |
Authors:
|
Jason W Heil; Laurel Malinowski; Andrea Rinderknecht; Joseph P Broderick; David Franz |
Related Documents
:
|
10763789 - Prevalence of apraxia among patients with a first left hemisphere stroke in rehabilitat... 7858279 - Patients' experience of rehabilitation after stroke. 9587989 - Diagnosis and monitoring of middle cerebral artery occlusion with contrast-enhanced tra... 17968519 - S100 as a marker of acute brain ischemia: a systematic review. 18647729 - Design and methods of a randomized controlled trial on early speech and language therap... 11453569 - Initial clinical and demographic predictors of swallowing impairment following acute st... 8977489 - Preservation of photic blink reflex in leber's hereditary optic neuropathy. 9629379 - Detection of metabolic disorders in high-risk patients. a pilot study in salvador, bahia. 22193369 - Frequency of established cardiovascular disease and its risk factors in chinese patient... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of child neurology Volume: 23 ISSN: 1708-8283 ISO Abbreviation: J. Child Neurol. Publication Date: 2008 Sep |
Date Detail:
|
Created Date: 2008-10-01 Completed Date: 2009-01-08 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 8606714 Medline TA: J Child Neurol Country: United States |
Other Details:
|
Languages: eng Pagination: 1049-53 Citation Subset: IM |
Affiliation:
|
University of Cincinnati, Department of Neurology, Cincinnati, Ohio 45267-0525, USA. heiljw@email.uc.edu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Basilar Artery / drug effects, pathology, physiopathology Blood Coagulation Disorders, Inherited / complications*, genetics*, physiopathology Brain Stem Infarctions / drug therapy, genetics, physiopathology Crohn Disease DNA Mutational Analysis Female Fibrinolytic Agents / administration & dosage Genetic Predisposition to Disease / genetics* Genetic Testing Genotype Humans Lupus Coagulation Inhibitor / blood, genetics Mutation / genetics Plasminogen Activator Inhibitor 1 / genetics Prothrombin / genetics Recovery of Function / drug effects Time Factors Tissue Plasminogen Activator / administration & dosage* Treatment Outcome Vertebrobasilar Insufficiency / drug therapy*, genetics*, physiopathology |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; 0/Lupus Coagulation Inhibitor; 0/Plasminogen Activator Inhibitor 1; 9001-26-7/Prothrombin; EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette sy...
Next Document: Divergent ependymal tumor (ependymoblastoma/anaplastic ependymoma) of the posterior fossa: an uncomm...